This HTML5 document contains 170 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.2165/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36648773
rdf:type
wikibase:Item
schema:description
videnskabelig artikel 2012年论文 2012年論文 bilimsel makale научная статья scientific article published on September 2012 artigo científico 2012年论文 vetenskaplig artikel מאמר מדעי tieteellinen artikkeli 2012年論文 научни чланак article scientifique scientific article published on September 2012 artikull shkencor 2012年论文 სამეცნიერო სტატია 2012年の論文 επιστημονικό άρθρο article científic наукова стаття, опублікована у вересні 2012 مقالة علمية نشرت في سبتمبر 2012 naučni članak 2012年论文 2012年論文 scienca artikolo научна статия artikel ilmiah tudományos cikk artigo científico teaduslik artikkel bài báo khoa học 2012년 논문 2012年論文 мақолаи илмӣ vedecký článok scientific article published on September 2012 artykuł naukowy artigo científico vědecký článek vitenskapelig artikkel 2012年论文 2012 nî lūn-bûn articol științific artículu científicu espublizáu en 2012 articolo scientifico artikulong pang-agham article scientific vitskapeleg artikkel 2012年论文 2012年論文 সেপ্টেম্বর ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wissenschaftlicher Artikel научни чланак wetenschappelijk artikel artículo científico publicado en 2012 บทความทางวิทยาศาสตร์
p:P577
wds:Q36648773-687A0210-4DFD-40BB-B567-38109835E271
wdt:P577
2012-09-01T00:00:00Z
p:P2860
wds:Q36648773-FA23CB93-F5D4-4D46-AB09-71DCB3F2B9B9 wds:Q36648773-FD7D2A73-8956-47F9-8697-A4D5C1035F08 wds:Q36648773-D8FA938C-A82F-4087-922D-8B18455E6444 wds:Q36648773-F8753844-7F12-404B-A1D7-321EC55A6177 wds:Q36648773-CD88EE93-208B-4C68-9854-1F1A9B815386 wds:Q36648773-D6AF7F1A-54DF-4793-BF32-1D2DB76C946E wds:Q36648773-4A65A751-3687-4BA5-BAD0-937252E07837 wds:Q36648773-4B652C64-AFDA-4BB4-B429-C95A3FF14CFC wds:Q36648773-5BC3D994-B648-4CAD-86F0-DC0509D8E90A wds:Q36648773-3B38CE1A-E082-45ED-9C3A-815E43A66DFF wds:Q36648773-4377B660-A726-417F-B319-423CC805FE58 wds:Q36648773-46833B61-18E3-4081-BB02-DE72E49BDC7A wds:Q36648773-3823C80F-8503-4F90-AE10-682DE61B0256 wds:Q36648773-3936AAF5-6C78-4362-839C-16EFE2B9BDA0 wds:Q36648773-39749834-56FD-47C4-95B6-CAE47CA5CCA4 wds:Q36648773-2A2931E6-4892-484D-AAF0-FF4FCB3A71C0 wds:Q36648773-2BE021E2-2E13-4382-BB2E-A6661FBB026A wds:Q36648773-903DE666-7A0F-426C-BACC-749FF6F27B9D wds:Q36648773-9B61F271-4FDD-4A77-9AA8-40FCD64C261D wds:Q36648773-C81FC09F-983E-45A3-9008-DF6FF8987076 wds:Q36648773-822DCD4C-39B9-481D-89E9-4BA685FFA6BF wds:Q36648773-8C534578-26D4-4DF9-A6BF-478AD8BAA25B wds:Q36648773-8E30C53F-3CCD-40F5-9C8D-04EB782D368D wds:Q36648773-66D2A81D-D5D1-4508-8C37-CE3BDBC8DEA7 wds:Q36648773-70047D9A-521A-46C0-B41F-0543084E0D7D wds:Q36648773-655293DE-C34D-44F9-A85B-DFDC46857129 wds:Q36648773-66069D1A-D658-46D2-A04E-880D8BCF6009 wds:Q36648773-07212110-8E69-4F78-A14F-7F00FD980C7E wds:Q36648773-11B09A1E-9FCC-45DF-9C85-F70DEF94828D wds:Q36648773-002CA12E-9C0F-4833-95CE-31F16AC965E5 wds:Q36648773-01EC7C57-5C7C-4DF5-80DB-5A6225BD65CA wds:Q36648773-04B12E92-D6FB-46A7-A473-FBCA7E9F974D
wdt:P2860
wd:Q34190402 wd:Q46634855 wd:Q42677538 wd:Q44451121 wd:Q28565765 wd:Q45201703 wd:Q57616579 wd:Q83364115 wd:Q74458799 wd:Q38958570 wd:Q37666983 wd:Q46322021 wd:Q36822516 wd:Q48273349 wd:Q43754366 wd:Q28287452 wd:Q53386775 wd:Q33162588 wd:Q33605319 wd:Q48133783 wd:Q46005660 wd:Q34628524 wd:Q44205013 wd:Q33876270 wd:Q73181932 wd:Q46659291 wd:Q39557334 wd:Q36379765 wd:Q37769873 wd:Q41713135 wd:Q35965791 wd:Q67931878
p:P2093
wds:Q36648773-7E8791CC-3F60-4C4D-A647-9326D1EBCBB4 wds:Q36648773-6D0F0AB7-7344-468E-9776-7C7B0C61ACBA wds:Q36648773-498CEAF3-89CB-4163-B8D4-EA0DCA030177 wds:Q36648773-5C6542B9-4724-4520-89F1-75B4FDD580B5 wds:Q36648773-2E134321-5B8C-48A9-8514-CA3AF73F9735 wds:Q36648773-13B358A6-7201-43DF-A75E-A741760AD036 wds:Q36648773-1092F529-62F9-45EC-A24A-09E412C3432A
wdt:P2093
Lev Gertsik Jacques Schipper Larry Ereshefsky Peter Dogterom Kari R Nations Roberta Bursi Tim Mant
rdfs:label
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection
skos:prefLabel
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection
schema:name
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection
p:P1476
wds:Q36648773-1AB5CF7B-5007-477D-B7D3-5A942ECB7A14
wdt:P1476
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection
p:P304
wds:Q36648773-0415C059-F9C5-441D-ACC1-523747AB9BC1
wdt:P304
127-139
p:P31
wds:Q36648773-D83D9A90-86F1-4425-947D-EF9B21629AF4
wdt:P31
wd:Q13442814
p:P698
wds:Q36648773-DDC0F762-47F7-4F6C-A267-541ED976DCDA
wdtn:P698
n12:22852579
wdt:P698
22852579
p:P1433
wds:Q36648773-C86ACE88-FBB2-425B-AE04-5A4C0F389AAB
wdt:P1433
wd:Q26842117
p:P433
wds:Q36648773-5CD8EACF-B4E7-4E16-ACED-AA20BFB99C89
p:P478
wds:Q36648773-A1D4624D-4E91-4F81-9884-10A571440335
wdt:P433
3
wdt:P478
12
p:P356
wds:Q36648773-CC2DFB3F-EEED-471D-8317-6D7D18D84FC3
wdtn:P356
n11:11634360-000000000-00000
wdt:P356
10.2165/11634360-000000000-00000
p:P5875
wds:Q36648773-625B9CAD-B255-422B-A035-56BB244DB949
wdt:P5875
230593822
p:P932
wds:Q36648773-1E17FE97-93C1-46C4-B91C-9C8396B22311
wdt:P932
3585695